Also, in ARQ's view this well is at an "exciting" stage. So the report can be construed many ways. However, the market cannot discount ARQ downplaying their enthusiasm. Their share performance has been woeful and the easiest way to erode faith would to overblow these well results at this stage...
spoke to company, page-9
Add EMR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$3.49 |
Change
-0.140(3.86%) |
Mkt cap ! $2.293B | |||
| Open | High | Low | Value | Volume |
| $3.65 | $3.66 | $3.49 | $49.57M | 14.78M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 13008 | $3.48 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.50 | 29569 | 3 |
View Market Depth
| Last trade - 16.10pm 14/11/2024 (20 minute delay) ? |
| EMR (ASX) Chart |